James N. Atkins, MD

Wayne Memorial Hospital, IncorporatedGoldsboro, North Carolina - 27534 (919-580-0000) Southeastern Medical Oncology Center - ...Goldsboro, North Carolina - 27534 (919-580-0000) Southeastern Medical Oncology CenterGoldsboro, North Carolina - 27534 |
- CLINICAL TRIALS 90
- CONDITIONS85
- INTERVENTIONS137
- SINCE

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
April 1999 -

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
January 2008 - June 2010

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
April 2008 - June 2011

Cisplatin Irinotecan and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
February 2006 - May 2007

Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012

Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
-

Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
May 2010 - April 2011

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012

Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer
July 2008 - August 2009

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
June 2007 - April 2012

Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
July 2009 - February 2012

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma
July 2010 - February 2012

Daunorubicin Cytarabine and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
April 2008 - July 2013

Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
December 2008 - February 2011

Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
-

Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
December 2008 - June 2010

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
January 2008 - May 2010

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
March 2008 - October 2008

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
September 2005 - January 2015

Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
March 2008 - May 2012

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer
April 2009 - December 2011

Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
December 2006 -

Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced High-Risk Neuroendocrine Tumor
December 2007 - January 2012

Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma or Plasmacytoma
June 2002 -

Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009

Paclitaxel Albumin-Stabilized Nanoparticle Formulation Doxorubicin Cyclophosphamide and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
April 2010 - June 2010

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
September 2006 - July 2008

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Genetic Study of Patients With Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes or Multiple Myeloma
June 1984 - July 2005

Dinaciclib in Treating Patients With Stage IV Melanoma
July 2009 - May 2010

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer
June 2009 - December 2013

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Genetic Study of Familial Factors in Patients With Colon Cancer
December 2001 -

Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia
August 2006 - February 2008

Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance
November 2003 -

Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
October 2007 - September 2012

Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
March 2005 -

Collecting Analyzing and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
February 1989 -

Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011

Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
July 2007 - November 2007

Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy
September 2009 - January 2012

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
June 2008 - December 2018

Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
April 2010 - January 2012

Collecting and Storing Blood Bone Marrow and Other Samples From Patients With Acute Leukemia Chronic Leukemia or Myelodysplastic Syndromes
May 1996 -

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
December 2006 - September 2011

Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
December 2008 - January 2011

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008

Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery
November 2008 - August 2009

Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009

Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
May 2008 - May 2009

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II Stage IIIA or Stage IIIB Breast Cancer
July 2009 - October 2013

Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
January 2004 - June 2013

Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
March 2007 - November 2011

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
July 2006 - April 2024

Capecitabine Gemcitabine and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
December 2008 - December 2010

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
July 1991 -

Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
May 2009 - July 2010

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative HER2-Negative Breast Cancer
May 2009 - January 2022

Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I Stage II or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
June 2006 - December 2012

Statins and Breast Cancer Biomarkers
January 2005 - December 2010

Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
April 1999 -

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012

Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
December 2008 - November 2010

Iodine I 131 Tositumomab Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma
September 2008 - October 2012

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
September 2010 - May 2015

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
April 2008 - August 2010

Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
August 2003 - July 2010

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I Stage II or Stage IIIA Breast Cancer
January 2007 - January 2010

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
November 2007 - October 2008

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
July 2009 - August 2011

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
March 2010 - January 2020

Cisplatin or Carboplatin and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
March 2007 - November 2011

Oxaliplatin Capecitabine Cetuximab and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
February 2009 - December 2011

L-Arginine Supplements in Treating Women Who Are Cancer Survivors
May 2007 - May 2010

Idarubicin Cytarabine and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
August 2009 - June 2011

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
July 2007 - June 2008

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
July 2010 - July 2013

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
-

Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
March 2010 - October 2011
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Prostatic Neoplasms
Amyloidosis
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Neoplasms
Neoplasm Metastasis
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Myelodysplastic Syndromes
Preleukemia
Leukemia, Myelomonocytic, Acute
Leukemia, Myelomonocytic, Chronic
Ovarian Neoplasms
Urinary Bladder Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Fatigue
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Bone Neoplasms
Bone Marrow Diseases
Lymphoma, T-Cell
Melanoma
Lymphedema
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Postoperative Complications
Mesothelioma
Carcinoma, Small Cell
Rectal Neoplasms
Infertility
Neurotoxicity Syndromes
Precancerous Conditions
Endometrial Neoplasms
Uterine Cervical Neoplasms
Hodgkin Disease
Myeloproliferative Disorders
Colorectal Neoplasms
Leukemia, Promyelocytic, Acute
Carcinoma, Transitional Cell
Lymphoma, Large-Cell, Immunoblastic
Neuroendocrine Tumors
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Hematologic Neoplasms
Cholangiocarcinoma
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Lymphoma, Follicular
Radiation Injuries
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Waldenstrom Macroglobulinemia
Carcinoma, Ductal, Breast
Lymphoma, Mantle-Cell
Gallbladder Neoplasms
Bile Duct Neoplasms
Ureteral Neoplasms
Carcinoma, Ductal
Osteonecrosis
Urologic Neoplasms
Carcinoma, Neuroendocrine
Monoclonal Gammopathies, Benign
Plasmacytoma
Paraproteinemias
Adenocarcinoma, Bronchiolo-Alveolar
Urethral Neoplasms
Placebo
Intensity-Modulated Radiation Therapy
Computed Tomography
Melphalan
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Complementary Or Alternative Medicine Procedure
Rituximab
Zoledronic Acid
Quality-Of-Life Assessment
Filgrastim
Exercise Intervention
Educational Intervention
Study Of Socioeconomic And Demographic Variables
Assessment Of Therapy Complications
Aflibercept
Fludeoxyglucose F 18
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Neoadjuvant Therapy
Therapeutic Conventional Surgery
Dasatinib
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Methotrexate
Methylprednisolone
Capecitabine
3-Dimensional Conformal Radiation Therapy
Oxaliplatin
Fludarabine Phosphate
Cytarabine
Doxorubicin Hydrochloride
Etoposide
Pegaspargase
Vincristine Sulfate
Temsirolimus
Bortezomib
Dexamethasone
Mercaptopurine
Polymerase Chain Reaction
Dna Methylation Analysis
Flow Cytometry
Reverse Transcriptase-Polymerase Chain Reaction
Sunitinib Malate
Vinblastine Sulfate
Goserelin
Leuprolide Acetate
Triptorelin
Microarray Analysis
Everolimus
Trastuzumab
Lapatinib Ditosylate
Pegfilgrastim
Cixutumumab
Sorafenib Tosylate
Western Blotting
Management Of Therapy Complications
Dna Analysis
Donepezil Hydrochloride
Thalidomide
Daunorubicin Hydrochloride
Thioguanine
Fluorescence In Situ Hybridization
Rosuvastatin
Conventional Surgery
Systemic Chemotherapy
Midostaurin
Azacitidine
Mutation Analysis
Cetuximab
Iodine I 131 Tositumomab
Biologic Sample Preservation Procedure
High Performance Liquid Chromatography
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Doxorubicin
Tamoxifen Citrate
Irinotecan Hydrochloride
Ixabepilone
Gemtuzumab Ozogamicin
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Topotecan Hydrochloride
Pravastatin
Dacarbazine
Letrozole
Nucleic Acid Sequencing
Ac Regimen
Vandetanib
Cytogenetic Analysis
Southern Blotting
Atorvastatin
Chemotherapy
Duloxetine Hydrochloride
Idarubicin
Clinical Observation
Therapeutic Thoracoscopy
Videothoracoscopy
Therapeutic Surgical Procedure
Exemestane
Bleomycin Sulfate
Abvd Regimen
Beacopp Regimen
Procarbazine Hydrochloride
Gene Mapping
Vinorelbine Ditartrate
Entinostat
Internet-Based Intervention
Placebo Administration
Recombinant Interferon Alfa-2b
Octreotide Acetate
Epirubicin Hydrochloride
Chromosomal Translocation Analysis
Dinaciclib
Tositumomab
Acetyl-L-Carnitine Hydrochloride
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
Sentinel Lymph Node Biopsy
Active Surveillance
Axillary Lymph Node Dissection
Ultrasound Imaging
Antiandrogen Therapy
Oophorectomy
L-Arginine/Korean Ginseng/ Gingko Biloba/Damiana-Based Supplement



